Table 1 Demographic and clinical features of patients suffering the first episode of PD related VS peritonitis
Overall VS peritonitis patients (N = 71) | mono-VS peritonitis (N = 57) | mixed-VS peritonitis (N = 14) | P * | |
|---|---|---|---|---|
Male (%) | 30 (42.3%) | 24 (42.1%) | 6 (42.9%) | 0.959 |
Age (years) (median, range) | 56 (16–81) | 56 (33–81) | 55.5 (16–72) | 0.275 |
First peritonitis after starting PD (months) | ||||
Median, range | 18.0 (0.6–144.0) | 18.0 (0.6–144.0) | 16.1(2.3–105.2) | 0.919 |
Time interval | ||||
< 6 | 13 (18.3%) | 11 (19.3%) | 2 (14.3%) | |
6–12 | 12 (16.9%) | 7 (12.3%) | 5 (35.7%) | |
12–24 | 17 (23.9%) | 16 (28.1%) | 1 (7.1%) | |
> 24 | 29 (40.8%) | 23 (40.4%) | 6 (42.9%) | |
Diabetes mellitus, n (%) | 9 (12.7%) | 9 (15.8%) | 0 (0%) | 0.112 |
Baseline albumin (gm/dl) (mean ± SD) | 3.46 ± 0.51 | 3.46 ± 0.49 | 3.48 ± 0.62 | 0.900 |
Baseline eGFR (ml/min/1.73m2) (median, range) | 6 (0–61) | 6 (0–61) | 11.5 (0–27) | 0.406 |
Baseline BMI (kg/m2) (median, range) | 22.5 (16.2–34.8) | 22.7 (16.2–34.8) | 21.7 (17.3–26.8) | 0.333 |
Prior antibiotic exposure, n (%) | 8 (11.3%) | 8 (14%) | 0 (0%) | 0.155 |